Cannabis' Impact on Alcohol Consumption
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Brown University
- Study ID
- NCT05389930
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Alcohol Drinking
- Alcohol Use Disorder
- Cannabis
- Cannabis Use
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- THC-dominant cannabis — DRUGSmoked cannabis with 9.53% THC and 0.09% CBD
- CBD-dominant cannabis — DRUGSmoked cannabis with 0.35% THC and 11.27% CBD
- Cannabis placebo — DRUGSmoked placebo cannabis plant material
- Alcohol — DRUGDrink containing 0.3 g/kg of alcohol
- Alcohol placebo — DRUGPlacebo beverage contains only juice and a negligible trace of alcohol for masking
Study Details
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Key Dates
- Start date
- Mar 16, 2023
- Status verified
- Aug 2024
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 350 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: THC-dominant cannabis dose367 mg of cannabis plant material with 9.53% THC and 0.09% CBD and 217 mg of placebo cannabis plant material will be mixed and smoked in a handheld pipe
- Experimental: CBD-dominant cannabis dose367 mg of cannabis plant material with 11.27% CBD and 0.35% THC and 217 mg of placebo cannabis plant material will be mixed and smoked in a handheld pipe
- Placebo Comparator: Placebo584 mg of cannabis plant material will be smoked in a handheld pipe
- Experimental: Alcohol priming doseAlcohol: 0.3 g/kg. Alcohol priming drink is designed to raise blood alcohol levels to 0.03 g/dl and be consumed in 5 minutes. The drink is mixed using 80-proof liquor and juice. Participants are randomized to receive either the experimental alcohol priming dose or alcohol placebo.
- Placebo Comparator: Alcohol placebo dosePlacebo beverage contains only juice and a negligible trace of alcohol for masking. The weight and sex-adjusted volume of alcohol and non-alcohol containing beverages will be equal. Participants are randomized to receive either the experimental alcohol priming dose or alcohol placebo.
Primary Outcome Measure
ml of alcohol consumed [ Time Frame: post-smoking during two-hours of the alcohol choice task ]
Central Contacts
- Jane Metrik, PhD401-863-6650
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brown University | Providence | Rhode Island | 02912 |
Find similar trials in Providence, RI
By condition
By specialty
By research site
Related Studies
- Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol TreatmentRecruiting · Butler Hospital · Providence, Rhode Island
- Developing a Positive Approach to Substance Use Prevention in North American Indian AdolescentsRecruiting · University of Rhode Island · Kingston, Rhode Island
- MDMA for AUD/PTSD ComorbidityPHASE2 · Recruiting · Carolina L Haass-Koffler · Providence, Rhode Island
- Intranasal Insulin for Treatment of Alcohol Use DisorderPHASE1/PHASE2 · Recruiting · Brown University · Providence, Rhode Island